Ultraviolet light (UV) represents one of the most relevant environmental factors influencing humans, especially with regard to its hazardous health effects, which include premature skin aging, skin cancer, and exacerbation of infectious diseases. Several of these effects are mediated by the immunosuppressive properties of UV. UV can compromise the immune system in several ways, e.g., by affecting the function of antigen-presenting
induction of hapten-specific T suppressor cells, because suppression can be transferred by injecting splenocytes from UV-exposed animals into naïve recipients (Elmets et al, 1983) . If, however, the hapten is painted onto nonirradiated skin after low-dose UV irradiation, these mice are still able to develop contact hypersensitivity (CHS) responses. Thus, this type of immunosuppression is referred to as local immunosuppression. Local immunosuppression appears to be genetically restricted, because it can only be induced in certain inbred strains of mice such as C3H/HeN and C57/BL6, whereas other strains seem to be resistant (BALB/C, C3H/HeJ). Because UV-induced local immunosuppression can be partially abrogated by antibodies against tumor necrosis factor α (TNFα), TNFα has been proposed to be an important mediator in this experimental system (Shimizu and Streilein, 1994) . These findings have been challenged by studies performed in TNF-receptor (p55)-deficient mice. Suppression of hapten-specific CHS responses in these gene-targeted mice is achievable by a lowdose UV regimen, suggesting that factors other than TNFα might mediate UV-induced local suppression of CHS responses (Kondo et al, 1995) .
The high-dose model leads to an inability to sensitize mice to contact allergens and alloantigens even through distant nonirradiated skin. In this model, also referred to as ''systemic immunosuppression'', the timing between UV exposure and sensitization is important, because sensitization shortly after UV treatment still leads to CHS or delayed type hypersensitivity (DTH) responses, whereas sensitization 4 d after UV fails to induce CHS/DTH responses (reviewed by . The high-UV-dose model system is also able to induce hapten-specific tolerance. Interestingly, serum from UV-exposed mice injected into nonirradiated naïve mice is able to suppress DTH responses. In addition, supernatants from UV-exposed keratinocytes injected in the same fashion into naïve recipients leads to inhibition of DTH responses. Both effects can be blocked by antibodies against interleukin (IL)-10, indicating that IL-10 is a key mediator of UVinduced systemic immunosuppression (Rivas and Ullrich, 1992) . Indeed, studies performed in IL-10-deficient mice show that highdose UV exposure is able to inhibit the development of CHS responses to contact allergens but not the DTH response to alloantigens, suggesting that the UV-induced suppression of DTH and CHS responses are differentially regulated . In high-UV-dose treated mice IL-10 serum concentrations peak between 2 and 4 d, indicating a delayed maximum of systemic immunosuppression after high-dose UV. In murine skin IL-10 is predominantly produced by keratinocytes after UV exposure, whereas in human skin it is mainly secreted by CD11 ϩ macrophages that infiltrate the skin after an UV insult (Kang et al, 1994) .
The strong induction of IL-10 by UV implies that UV exposure might be able to shift cellular immune responses towards a Th2-type pattern. Therefore, it was speculated whether IL-12, which favors the development of a Th1-type response and which is essential for the induction of CHS (Müller et al, 1995; Riemann et al, 1996) , is able to abrogate the immunosuppressive effects of UV. Indeed, administration of IL-12 prior to UV treatment counteracts the UV-induced systemic suppression of DTH responses to alloantigens (Schmitt et al, 1995) . Moreover, treatment with IL-12 was also able to antagonize the UV-induced local immunosuppression as well as the UV-induced hapten-specific tolerance (Müller et al, 1995; Schwarz et al, 1996) . This prompted recent studies with CTLA-4Ig transgenic mice having had the CTLA4 gene placed under the control of the keratin-14 promoter. These animals constitutively express soluble CTLA-4Ig in the epidermis and the serum and are prone to a Th1-type immune response. Interestingly, high-UV-dose irradiation cannot suppress the induction of DTH responses to alloantigens as in wild-type mice (Beissert and Schwarz, unpublished observation) . These data further support the concept that UV suppresses the immune system by skewing the immune responses towards the Th2-type.
EFFECTS OF UV ON ANTIGEN PRESENTATION
Within the epidermis, dendritic Langerhans cells are the major antigenpresenting cell (APC). Exposure of skin to UV results in a profound depletion of Langerhans cells, which might account for the inhibition of the induction of CHS following solar irradiation (Toews et al, 1980) . In addition, UV suppresses the expression of MHC class II surface molecules and ATPase activity in Langerhans cells (Aberer et al, 1981) . Furthermore, inhibition of ICAM-1 expression by UV may be responsible for impaired clustering between Langerhans cells and T cells. In vitro, UV exposure differentially affects Langerhans cells in their capacity to stimulate different subsets of CD4 ϩ T cell clones. Whereas UV-treated Langerhans cells are unable to stimulate T cell clones of the Th1 type, their ability to stimulate Th2 clones is unaffected by UV (Simon et al, 1990) .
This impairment of APC function by UV is dose dependent and has been observed in vivo and in vitro. Other APC such as human peripheral blood-derived dendritic cells exposed to UV and splenic dendritic cells from UV-treated mice, have also been found to be significantly impaired in their capacities to stimulate allogeneic T cells, indicating that UV-induced suppression of APC function is not specific for Langerhans cells. Of particular interest in this context is the finding that UV exposure suppresses the expression of the costimulatory B7 surface molecules (CD80/86). CD80/86 are expressed on Langerhans cells and other APC and play an important role in interactions between APC and T cells. UV downregulates the expression of CD80 and CD86 on human Langerhans cells in vitro and CD80 on blood-derived dendritic cells in vitro (Young et al, 1993; Weiss et al, 1995) ; however, these findings have been challenged by the observation that the expression of CD80 and CD86 is upregulated after in vivo irradiation of human skin with erythematogenic doses of solar-simulating UV (Laihia and Jansen, 1997) . More information on the mechanisms by which UV impairs antigen presentation has been delivered by in vitro studies using the Langerhans cell-like dendritic cell line XS52. Treatment of XS52 cells with catalase prior to UVB significantly blocks the UV-induced inhibition of APC function. This suggests that hydrogen peroxide is involved in UV-induced inhibition of antigen presentation, especially because addition of hydrogen peroxide alone to XS52 cells also impairs their allostimulatory capacity (Caceres-Dittmar et al, 1995) . Taken together, these data indicate that UV is able to suppress APC function directly by suppressing costimulatory molecules and indirectly via the generation of hydrogen peroxide and the release of soluble mediators that will be discussed below.
The major cellular component of the epidermis are keratinocytes, and they thus represent the primary cellular target for environmental UV. Upon UV exposure keratinocytes produce and secrete a large number of soluble mediators, including eicosanoids and cytokines, some of them with inflammatory or immunosuppressive properties (reviewed by Luger and Schwarz, 1995) . Most of these factors have also been detected in the serum of UV-exposed human volunteers and mice, suggesting that UV-induced mediators are able to reach the circulation to exert their systemic effects. This has been demonstrated especially for the proinflammatory cytokines IL-1, IL-6, and TNFα (Urbanski et al, 1990) . Epidermal Langerhans cells reside in close vicinity of keratinocytes and their APC function is strongly affected by the release of cytokines from surrounding keratinocytes. Because keratinocytes are virtually ''cytokine factories'' it is difficult to dissect the effects of a single factor on Langerhans cell antigen presentation. In order to address this issue, a model of tumor immunity was developed (Grabbe et al, 1991) . Epidermal Langerhans cells were prepared ex vivo from murine skins (H2 a/d ) and cultured in granulocyte macrophage colony stimulating factor (GM-CSF), which is necessary for successful maturation of Langerhans cells in this system. Subsequently, these Langerhans cells were exposed to tumor-associated antigens from the chemically induced murine spindle-cell tumor S1509a (H2 a ) and used for immunization of naive mice (H2 a/d ) against this tumor. Mice immunized by Langerhans cells pulsed with tumor antigens rejected subcutaneously inoculated viable S1509a tumor cells, indicating that Langerhans cells are able to present tumor antigens for the induction of protective tumor immunity (Grabbe et al, 1991) . In this model Langerhans cells were cultured in different UV-inducible cytokines to investigate their effects on APC function. Treatment of Langerhans cells with GM-CSF plus IL-10 or IL-10 treatment after GM-CSF culture did not suppress the ability of Langerhans cells to induce tumor immunity. Langerhans cells cultured with IL-10 prior to GM-CSF, however, were unable to induce antitumoral immune responses (Beissert et al, 1995) . Recently, a downregulation of IL-10 receptors on APC during maturation was found that could explain these early inhibitory effects of IL-10 on Langerhans cells and the relative resistance of matured Langerhans cells to IL-10. IL-10 has been shown to downregulate costimulatory B7 expression on APC, thereby inhibiting antigen presentation. On the other hand, Langerhans cells cultured with TNFα prior to GM-CSF or with TNFα plus GM-CSF were able to induce immunity; although treatment of Langerhans cells with TNFα after GM-CSF exposure inhibited their antigen-presenting function (Grabbe et al, 1992) . This suggests that IL-10 acts as an early ''off-switch'' and TNFα as a late ''off-switch'' of Langerhans cell APC function. Another cytokine that is released from keratinocytes after UV is IL-1. IL-1 exists in two forms, IL-1α and IL-1β. IL-1α, but not IL-1β, is able to functionally suppress Langerhans cells. These findings suggest that the immunosuppressive effects of UV can be mediated via the release of several cytokines, which themselves inhibit antigen presentation and the induction of immune responses.
A chromophore in the epidermis that has been identified to participate in the complex mechanisms of UV-induced immunosuppression is urocanic acid (UCA) (reviewed by Norval et al, 1995) . UCA is generated in the metabolic pathway of the essential amino acid histidine. It accumulates in the epidermis as epidermal cells, in contrast to liver cells, lack the necessary enzymes to further catabolize UCA. UCA exists in the two tautomeric forms, trans (E)-and cis (Z)-UCA. The isoform primarily found in the epidermis is trans-UCA. Trans-UCA contains an acyclic carbon-carbon double bond and absorbs in the UVB range. UCA is thereby photoisomerized from trans-to cis-UCA. The photostationary state between the two isoforms in vivo is 45% trans-UCA and 55% cis-UCA. The UV-induced isomer cis-UCA has been shown to be involved in UV-induced immunosuppression, because injection of cis-UCA could partially mimic the immunoinhibitory activity of UV and removal of UCA by tape stripping of murine epidermis resulted in the loss of the particular immunosuppressive effects of UV (DeFabo and Noonan, 1983 ). This has been further substantiated as anti-cis-UCA antibodies were able to partially restore hapten-specific immune responses after UV. Recently, cis-UCA has also been demonstrated to inhibit Langerhans cell presentation of tumor antigens (Beissert et al, 1997) .
In addition to cytokines, neurogenic peptides such as calcitonin gene-related peptide (CGRP) and nitric oxide also seem to play a role in mediating UV-induced immunosuppression. This hypothesis is supported by investigations studying the effects of the CGRP receptor antagonist ) and the nitric oxide synthase inhibitor L-NAME (N-nitro-L-arginine methylester) topically applied to rodent skin after UV irradiation (Gillardon et al, 1995) . Such treatment following UV but prior to immunization to contact allergens, was able to almost completely restore the UV-induced suppression of CHS responses.
MOLECULAR TARGETS FOR UV LIGHT
DNA is the major UVB-absorbing cellular chromophore in the skin. Following UVB exposure the most frequent photoproducts found are pyrimidinedimers and (6-4)-photoproducts. UV-induced dimer formation has been proposed to play a crucial role in UV-induced immunosuppression. Data to support this hypothesis originate from investigations using the DNA excision repair enzyme T4 endonuclease V (T4N5) encapsulated in liposomes (Yarosh et al, 1994) . Topical application of T4N5 significantly antagonized the immunosuppressive effects of UV, e.g., the inhibition of the induction of CHS (Kripke et al, 1992) . There is also evidence that DNA damage triggers cytokine release because UVB-induced secretion of IL-10 and TNF by keratinocytes was significantly suppressed after additon of T4N5 (Nishigori et al, 1996; Kibitel et al, 1998) . Together, these data strongly suggest that DNA damage is an important inducer of UV-induced immunosuppression.
There is also accumulating evidence, however, that UV may also affect cytoplasmic and membrane targets (reviewed in Schwarz, 1998) . Briefly, UV can directly trigger surface receptors by inducing either their phosphorylation (Sachsenmaier et al, 1994) or oligomerization (Rosette and Karin, 1996; Aragane et al, 1998) and can activate tyrosine kinases closely located to the cell membrane (Devary et al, 1992) . Recently it was observed that UV can also exert its immunosuppressive effects by affecting targets at the cell membrane. UV exposure of keratinocytes inhibits interferon-γ (IFNγ) induced release of IL-7; however, UV does not directly suppress the IL-7 gene but rather prevents IFN from exerting its inducing effect (Aragane et al, 1997a) . This is due to the inhibition of the expression of the transcription factor interferon regulatory factor-1 (IRF-1), which is crucial for IFNγ signaling. Suppression of IFNγ-induced IRF-1 expression by UV appears be due to inhibition of the phosphorylation of STAT-1, a signal transducing protein that is an essential member of the IFNγ signal transduction cascade (Aragane et al, 1997b) . Upon binding of IFNγ to its receptor, STAT-1 is tyrosine phosphorylated, dimerizes and thus can actively bind DNA. Consequently STAT-1 migrates to the nucleus and hooks to specific responsive elements in the IRF-promoter region, thereby activating IRF-1 transcription. The mechanism by which UV inhibits phosphorylation of STAT-1 and consequently shuts off the IFNγ response remains to be determined. Nevertheless, these data demonstrate that UV does not only affect the release of cytokines but can also interfere with the biologic effects of these mediators preferentially by downregulating transcription factors. Because tyrosine phosphorylation of STAT-1 is an event occurring at or at least very close to the cell membrane, this observation further supports the view that UV not only affects nuclear targets, preferentially DNA, but can also affect molecules within the cytoplasm or at the cell membrane.
LINK BETWEEN APOPTOSIS AND UV-INDUCED IMMUNOSUPPRESSION
Although the involvement of T suppressor cells in the mediation of UV-induced tolerance has been described more than a decade ago, the mechanisms by which T suppressor cells act still remain unclear. There is increasing evidence that apoptosis may play an important role in immune reactions (reviewed by Lynch et al, 1995) . CD95 (Fas or APO-1) is a surface receptor that mediates apoptosis upon being triggered by its ligand CD95L (FasL) (reviewed by Nagata, 1997 (Hahne et al, 1996) . Because tolerance can also be regarded as a form of immune privilege, it was investigated whether the CD95/CD95L system plays a role in UV-induced tolerance. This issue was addressed by using lpr mice that lack functional CD95 and gld mice that lack CD95L. Lowdose UV exposure of both strains inhibited the induction of CHS, suggesting that lpr and gld mice were UV-susceptible. In contrast to UV-exposed C3H/HeN mice, UV-exposed lpr and gld mice did not develop tolerance . This observation implied that the CD95/CD95L system is crucial for the development of tolerance. Cross transfer experiments between C3H/HeN, lpr, and gld mice revealed that the transfer of tolerance does not require CD95 or CD95L expression on the suppressor cells but requires both molecules on cells in the recipient .
These unexpected findings were compatible with the theory that T suppressor cells do not kill their targets via expression of CD95L themselves, but rather drive cells that are essential during sensitization into apoptosis in the recipient, and that this may be mediated via the CD95/CD95L system. Accordingly, in vitro experiments showed that bone marrow derived dendritic cells upon coincubation with T cells obtained from UV-tolerized mice die at a significantly increased rate via apoptosis . This observation suggests that T suppressor cells mediate their inhibitory property by inducing apoptosis of APC and that the CD95/CD95L sytem is crucially involved in this process. Addition of IL-12, which is known to break established UV-mediated tolerance (Müller et al, 1995; Schmitt et al, 1995; Schwarz et al, 1996) , to cocultures of T suppressor cells and dendritic cells significantly reduced the number of dead dendritic cells . Based on these findings one can speculate that IL-12 can break tolerance by rescuing dendritic cells from T suppressor cell induced apoptosis.
